Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394940 · ClinicalTrials.gov registry record
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
A clinical trial of Chronic Obstructive Pulmonary Disease, sponsored by University of Arizona.
- Completed
- Registry status
- 2,085
- Enrollment target
- 1
- Study location
NCT00394940 is a study of Chronic Obstructive Pulmonary Disease that has completed, run by University of Arizona. The registered enrollment target is 2,085 participants, above the 1,730-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00394940, a study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 2,085 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic obstructive pulmonary disease (COPD) is a condition that is characterized by airway obstruction due to inflammation. Levels of inflammatory proteins may be linked to when and to what extent COPD develops. This study will use data collected during the Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD) and its 33-year follow-up to determine the relationship between inflammatory protein expression and COPD.
Conditions Studied
Study Locations (1)
Arizona
- Arizona Respiratory Center - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,085 participants |
| Start Date | 2006-07 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00394940
The ClinicalTrials.gov registry entry for NCT00394940 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,085 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,730-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (21% higher). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00394940 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT00394940 about?
NCT00394940 is a clinical study titled "Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease". Chronic obstructive pulmonary disease (COPD) is a condition that is characterized by airway obstruction due to inflammation. Levels of inflammatory proteins may be linked to when and to what extent COPD develops. This study will use data collected during the Tucson Epidemiological Study of Airway Ob...
What is the current status of trial NCT00394940?
This trial is currently completed. The enrollment target is 2,085 participants. The study started on 2006-07. Estimated completion is 2013-01.
What conditions does trial NCT00394940 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.
Who is sponsoring clinical trial NCT00394940?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00394940 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
RECRUITING
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
COPD Care Pathway Among Patients With Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.